| Year |
Citation |
Score |
| 2021 |
Mahmood RD, Shaw D, Descamps T, Zhou C, Morgan RD, Mullamitha S, Saunders M, Mescallado N, Backen A, Morris K, Little RA, Cheung S, Watson Y, O'Connor JPB, Jackson A, et al. Effect of oxaliplatin plus 5-fluorouracil or capecitabine on circulating and imaging biomarkers in patients with metastatic colorectal cancer: a prospective biomarker study. Bmc Cancer. 21: 354. PMID 33794823 DOI: 10.1186/s12885-021-08097-9 |
0.301 |
|
| 2016 |
Sharma RA, Plummer R, Stock JK, Greenhalgh TA, Ataman O, Kelly S, Clay R, Adams RA, Baird RD, Billingham L, Brown SR, Buckland S, Bulbeck H, Chalmers AJ, Clack G, ... ... Saunders MP, et al. Clinical development of new drug-radiotherapy combinations. Nature Reviews. Clinical Oncology. PMID 27245279 DOI: 10.1038/nrclinonc.2016.79 |
0.302 |
|
| 2013 |
Horsley L, Cummings J, Middleton M, Ward T, Backen A, Clamp A, Dawson M, Farmer H, Fisher N, Halbert G, Halford S, Harris A, Hasan J, Hogg P, Kumaran G, ... ... Saunders M, et al. A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours. Cancer Chemotherapy and Pharmacology. 72: 1343-52. PMID 24141375 DOI: 10.1007/s00280-013-2320-9 |
0.388 |
|
| 2003 |
Patterson AV, Saunders MP, Greco O. Prodrugs in genetic chemoradiotherapy. Current Pharmaceutical Design. 9: 2131-54. PMID 14529410 DOI: 10.2174/1381612033454117 |
0.395 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2009 |
Bennouna J, Saunders M, Douillard JY. The role of UFT in metastatic colorectal cancer. Oncology. 76: 301-10. PMID 19299903 DOI: 10.1159/000209334 |
0.293 |
|
| 2022 |
Hudson EM, Noutch S, Brown S, Adapala R, Bach SP, Burnett C, Burrage A, Gilbert A, Hawkins M, Howard D, Jefford M, Kochhar R, Saunders M, Seligmann J, Smith A, et al. A Phase II trial of Higher RadiOtherapy Dose In The Eradication of early rectal cancer (APHRODITE): protocol for a multicentre, open-label randomised controlled trial. Bmj Open. 12: e049119. PMID 35487526 DOI: 10.1136/bmjopen-2021-049119 |
0.277 |
|
| 2020 |
André T, Saunders M, Kanehisa A, Gandossi E, Fougeray R, Amellal NC, Falcone A. First-line trifluridine/tipiracil plus bevacizumab for unresectable metastatic colorectal cancer: SOLSTICE study design. Future Oncology (London, England). PMID 31914811 DOI: 10.2217/fon-2019-0786 |
0.273 |
|
| 2013 |
Cunningham D, Lang I, Marcuello E, Lorusso V, Ocvirk J, Shin DB, Jonker D, Osborne S, Andre N, Waterkamp D, Saunders MP. Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial. The Lancet. Oncology. 14: 1077-85. PMID 24028813 DOI: 10.1016/S1470-2045(13)70154-2 |
0.269 |
|
| 2015 |
Krebs MG, Renehan AG, Backen A, Gollins S, Chau I, Hasan J, Valle JW, Morris K, Beech J, Ashcroft L, Saunders MP, Dive C. Circulating Tumor Cell Enumeration in a Phase II Trial of a Four-Drug Regimen in Advanced Colorectal Cancer. Clinical Colorectal Cancer. 14: 115-22.e1-2. PMID 25680623 DOI: 10.1016/j.clcc.2014.12.006 |
0.269 |
|
| 2016 |
Freeman K, Saunders MP, Uthman OA, Taylor-Phillips S, Connock M, Court R, Gurung T, Sutcliffe P, Clarke A. Is monitoring of plasma 5-fluorouracil levels in metastatic / advanced colorectal cancer clinically effective? A systematic review. Bmc Cancer. 16: 523. PMID 27456697 DOI: 10.1186/S12885-016-2581-X |
0.268 |
|
| 2009 |
Ferraldeschi R, Minchell LJ, Roberts SA, Tobi S, Hadfield KD, Blackhall FH, Mullamitha S, Wilson G, Valle J, Saunders M, Newman WG. UGT1A1*28 genotype predicts gastrointestinal toxicity in patients treated with intermediate-dose irinotecan. Pharmacogenomics. 10: 733-9. PMID 19450125 DOI: 10.2217/pgs.09.20 |
0.262 |
|
| 2022 |
André T, Falcone A, Shparyk Y, Moiseenko F, Polo-Marques E, Csöszi T, Campos-Bragagnoli A, Liposits G, Chmielowska E, Aubel P, Martín L, Fougeray R, Amellal N, Saunders MP. Trifluridine-tipiracil plus bevacizumab versus capecitabine plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer ineligible for intensive therapy (SOLSTICE): a randomised, open-label phase 3 study. The Lancet. Gastroenterology & Hepatology. PMID 36470291 DOI: 10.1016/S2468-1253(22)00334-X |
0.259 |
|
| 2006 |
Clayton AJ, Mansoor AW, Jones ET, Hawkins RE, Saunders MP, Swindell R, Valle JW. A phase II study of weekly cisplatin and gemcitabine in patients with advanced pancreatic cancer: is this a strategy still worth pursuing? Pancreas. 32: 51-7. PMID 16340744 |
0.255 |
|
| 2007 |
Jansen EP, Boot H, Saunders MP, Crosby TD, Dubbelman R, Bartelink H, Verheij M, Cats A. A phase I-II study of postoperative capecitabine-based chemoradiotherapy in gastric cancer. International Journal of Radiation Oncology, Biology, Physics. 69: 1424-8. PMID 17689023 DOI: 10.1016/J.Ijrobp.2007.05.004 |
0.251 |
|
| 2018 |
Robles-Zurita J, Boyd KA, Briggs AH, Iveson T, Kerr RS, Saunders MP, Cassidy J, Hollander NH, Tabernero J, Segelov E, Glimelius B, Harkin A, Allan K, McQueen J, Pearson S, et al. SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer. British Journal of Cancer. PMID 30420616 DOI: 10.1038/S41416-018-0319-Z |
0.248 |
|
| 2020 |
Rao S, Sclafani F, Eng C, Adams RA, Guren MG, Sebag-Montefiore D, Benson A, Bryant A, Peckitt C, Segelov E, Roy A, Seymour MT, Welch J, Saunders MP, Muirhead R, et al. International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1903266. PMID 32530769 DOI: 10.1200/JCO.19.03266 |
0.248 |
|
| 2018 |
Iveson TJ, Kerr RS, Saunders MP, Cassidy J, Hollander NH, Tabernero J, Haydon A, Glimelius B, Harkin A, Allan K, McQueen J, Scudder C, Boyd KA, Briggs A, Waterston A, et al. 3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial. The Lancet. Oncology. 19: 562-578. PMID 29611518 DOI: 10.1016/S1470-2045(18)30093-7 |
0.244 |
|
| 2013 |
James RD, Glynne-Jones R, Meadows HM, Cunningham D, Myint AS, Saunders MP, Maughan T, McDonald A, Essapen S, Leslie M, Falk S, Wilson C, Gollins S, Begum R, Ledermann J, et al. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial. The Lancet. Oncology. 14: 516-24. PMID 23578724 DOI: 10.1016/S1470-2045(13)70086-X |
0.243 |
|
| 2021 |
Hanna CR, O'Cathail SM, Graham JS, Saunders M, Samuel L, Harrison M, Devlin L, Edwards J, Gaya DR, Kelly CA, Lewsley LA, Maka N, Morrison P, Dinnett L, Dillon S, et al. Correction to: Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT). Radiation Oncology (London, England). 16: 230. PMID 34857017 DOI: 10.1186/s13014-021-01941-z |
0.243 |
|
| 2010 |
Tebbutt NC, Wilson K, Gebski VJ, Cummins MM, Zannino D, van Hazel GA, Robinson B, Broad A, Ganju V, Ackland SP, Forgeson G, Cunningham D, Saunders MP, Stockler MR, Chua Y, et al. Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 3191-8. PMID 20516443 DOI: 10.1200/JCO.2009.27.7723 |
0.24 |
|
| 2009 |
Saunders MP, Wilson R, Peeters M, Smith R, Godwood A, Oliver S, Van Cutsem E. Vandetanib with FOLFIRI in patients with advanced colorectal adenocarcinoma: results from an open-label, multicentre Phase I study. Cancer Chemotherapy and Pharmacology. 64: 665-72. PMID 19184020 DOI: 10.1007/s00280-008-0914-4 |
0.234 |
|
| 2018 |
Beech J, Germetaki T, Judge M, Paton N, Collins J, Garbutt A, Braun M, Fenwick J, Saunders MP. Management and grading of EGFR inhibitor-induced cutaneous toxicity. Future Oncology (London, England). PMID 29727211 DOI: 10.2217/fon-2018-0187 |
0.233 |
|
| 2020 |
André T, Meyerhardt J, Iveson T, Sobrero A, Yoshino T, Souglakos I, Grothey A, Niedzwiecki D, Saunders M, Labianca R, Yamanaka T, Boukovinas I, Vernerey D, Meyers J, Harkin A, et al. Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials. The Lancet. Oncology. 21: 1620-1629. PMID 33271092 DOI: 10.1016/S1470-2045(20)30527-1 |
0.232 |
|
| 2012 |
Hoff PM, Hochhaus A, Pestalozzi BC, Tebbutt NC, Li J, Kim TW, Koynov KD, Kurteva G, Pintér T, Cheng Y, van Eyll B, Pike L, Fielding A, Robertson JD, Saunders MP. Cediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase III study (HORIZON II). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 3596-603. PMID 22965965 DOI: 10.1200/JCO.2012.42.6031 |
0.231 |
|
| 2022 |
Propper DJ, Gao F, Saunders MP, Sarker D, Hartley JA, Spanswick VJ, Lowe HL, Hackett LD, Ng TT, Barber PR, Weitsman GE, Pearce S, White L, Lopes A, Forsyth S, et al. PANTHER: AZD8931, inhibitor of EGFR, ERBB2 and ERBB3 signalling, combined with FOLFIRI: a Phase I/II study to determine the importance of schedule and activity in colorectal cancer. British Journal of Cancer. PMID 36352028 DOI: 10.1038/s41416-022-02015-x |
0.229 |
|
| 2021 |
Iyengar P, Zhang-Velten E, Court L, Westover K, Yan Y, Lin MH, Xiong Z, Patel M, Rivera D, Chang J, Saunders M, Shivnani A, Lee A, Hughes R, Gerber D, et al. Accelerated Hypofractionated Image-Guided vs Conventional Radiotherapy for Patients With Stage II/III Non-Small Cell Lung Cancer and Poor Performance Status: A Randomized Clinical Trial. Jama Oncology. PMID 34383006 DOI: 10.1001/jamaoncol.2021.3186 |
0.229 |
|
| 2023 |
Williams CJM, Elliott F, Sapanara N, Aghaei F, Zhang L, Muranyi A, Yan D, Bai I, Zhao Z, Shires M, Wood HM, Richman SD, Hemmings G, Hale M, Bottomley D, ... ... Saunders M, et al. Associations between AI-assisted tumor amphiregulin and epiregulin IHC and outcomes from anti-EGFR therapy in the routine management of metastatic colorectal cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 37363997 DOI: 10.1158/1078-0432.CCR-23-0859 |
0.228 |
|
| 2021 |
Hanna CR, O'Cathail SM, Graham JS, Saunders M, Samuel L, Harrison M, Devlin L, Edwards J, Gaya DR, Kelly CA, Lewsley LA, Maka N, Morrison P, Dinnett L, Dillon S, et al. Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT). Radiation Oncology (London, England). 16: 163. PMID 34446053 DOI: 10.1186/s13014-021-01888-1 |
0.227 |
|
| 2015 |
Freeman K, Connock M, Cummins E, Gurung T, Taylor-Phillips S, Court R, Saunders M, Clarke A, Sutcliffe P. Fluorouracil plasma monitoring: systematic review and economic evaluation of the My5-FU assay for guiding dose adjustment in patients receiving fluorouracil chemotherapy by continuous infusion. Health Technology Assessment (Winchester, England). 19: 1-322. PMID 26542268 DOI: 10.3310/Hta19910 |
0.225 |
|
| 2006 |
Harrop R, Connolly N, Redchenko I, Valle J, Saunders M, Ryan MG, Myers KA, Drury N, Kingsman SM, Hawkins RE, Carroll MW. Vaccination of colorectal cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) induces immune responses which correlate with disease control: a phase I/II trial. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 3416-24. PMID 16740766 DOI: 10.1158/1078-0432.CCR-05-2732 |
0.224 |
|
| 2017 |
Hickish T, Andre T, Wyrwicz L, Saunders M, Sarosiek T, Kocsis J, Nemecek R, Rogowski W, Lesniewski-Kmak K, Petruzelka L, Apte RN, Mohanty P, Stecher M, Simard J, de Gramont A. MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study. The Lancet. Oncology. PMID 28094194 DOI: 10.1016/S1470-2045(17)30006-2 |
0.224 |
|
| 2008 |
Albanell J, Montagut C, Jones ET, Pronk L, Mellado B, Beech J, Gascon P, Zugmaier G, Brewster M, Saunders MP, Valle JW. A phase I study of the safety and pharmacokinetics of the combination of pertuzumab (rhuMab 2C4) and capecitabine in patients with advanced solid tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 2726-31. PMID 18451238 DOI: 10.1158/1078-0432.CCR-07-1980 |
0.221 |
|
| 2023 |
Wyrwicz L, Saunders MP, Hall M, Ng J, Hong T, Xu S, Lucas J, Lu X, Lautermilch N, Formenti S, Glynne-Jones R. AN0025, a novel antagonist of PGE2-receptor E-type 4 (EP4), in combination with total neoadjuvant treatment of advanced rectal cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 109669. PMID 37054987 DOI: 10.1016/j.radonc.2023.109669 |
0.217 |
|
| 2018 |
Grothey A, Sobrero AF, Shields AF, Yoshino T, Paul J, Taieb J, Souglakos J, Shi Q, Kerr R, Labianca R, Meyerhardt JA, Vernerey D, Yamanaka T, Boukovinas I, Meyers JP, ... ... Saunders M, et al. Duration of Adjuvant Chemotherapy for Stage III Colon Cancer. The New England Journal of Medicine. 378: 1177-1188. PMID 29590544 DOI: 10.1056/Nejmoa1713709 |
0.214 |
|
| 2021 |
Kamposioras K, Lim KHJ, Williams J, Alani M, Barriuso J, Collins J, Marti K, Braun M, Mullamitha S, Hasan J, Alam N, Mahmood S, Finch S, Bayles L, King J, ... Saunders M, et al. Modification to Systemic Anticancer Therapy at the Start of the COVID-19 Pandemic and its Overall Impact on Survival Outcomes in Patients with Colorectal Cancer. Clinical Colorectal Cancer. PMID 34953674 DOI: 10.1016/j.clcc.2021.11.010 |
0.212 |
|
| 2015 |
Argilés G, Saunders MP, Rivera F, Sobrero A, Benson A, Guillén Ponce C, Cascinu S, Van Cutsem E, Macpherson IR, Strumberg D, Köhne CH, Zalcberg J, Wagner A, Luigi Garosi V, Grunert J, et al. Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trial. European Journal of Cancer (Oxford, England : 1990). 51: 942-9. PMID 25818084 DOI: 10.1016/j.ejca.2015.02.013 |
0.211 |
|
| 2014 |
Khoja L, Kumaran G, Zee YK, Murukesh N, Swindell R, Saunders MP, Clamp AR, Valle JW, Wilson G, Jayson GC, Hasan J. Evaluation of hypertension and proteinuria as markers of efficacy in antiangiogenic therapy for metastatic colorectal cancer. Journal of Clinical Gastroenterology. 48: 430-4. PMID 24153157 DOI: 10.1097/MCG.0b013e3182a8804c |
0.211 |
|
| 2007 |
Matzow T, Cowen RL, Williams KJ, Telfer BA, Flint PJ, Southgate TD, Saunders MP. Hypoxia-targeted over-expression of carboxylesterase as a means of increasing tumour sensitivity to irinotecan (CPT-11). The Journal of Gene Medicine. 9: 244-52. PMID 17397102 DOI: 10.1002/jgm.1016 |
0.205 |
|
| 2015 |
Renehan AG, Malcomson L, Emsley R, Gollins S, Maw A, Myint AS, Rooney PS, Susnerwala S, Blower A, Saunders MP, Wilson MS, Scott N, O'Dwyer ST. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis. The Lancet. Oncology. PMID 26705854 DOI: 10.1016/S1470-2045(15)00467-2 |
0.204 |
|
| 2017 |
Kochhar R, Renehan AG, Mullan D, Chakrabarty B, Saunders MP, Carrington BM. The assessment of local response using magnetic resonance imaging at 3- and 6-month post chemoradiotherapy in patients with anal cancer. European Radiology. 27: 607-617. PMID 27090113 DOI: 10.1007/s00330-016-4337-z |
0.201 |
|
| 2021 |
Hanna CR, Robles-Zurita JA, Briggs A, Harkin A, Kelly C, McQueen J, Allan K, Pearson S, Hollander H, Glimelius B, Salazar R, Segelov E, Saunders M, Iveson T, Jones RJ, et al. Three Versus Six Months of Adjuvant Doublet Chemotherapy for Patients With Colorectal Cancer: A Multi-Country Cost-Effectiveness and Budget Impact Analysis. Clinical Colorectal Cancer. PMID 33992542 DOI: 10.1016/j.clcc.2021.04.001 |
0.199 |
|
| 2002 |
Renehan AG, Egger M, Saunders MP, O'Dwyer ST. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. Bmj (Clinical Research Ed.). 324: 813. PMID 11934773 DOI: 10.1136/bmj.324.7341.813 |
0.199 |
|
| 2018 |
Chadi SA, Malcomson L, Ensor J, Riley RD, Vaccaro CA, Rossi GL, Daniels IR, Smart NJ, Osborne ME, Beets GL, Maas M, Bitterman DS, Du K, Gollins S, Sun Myint A, ... ... Saunders MP, et al. Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis. The Lancet. Gastroenterology & Hepatology. PMID 30318451 DOI: 10.1016/S2468-1253(18)30301-7 |
0.198 |
|
| 2018 |
Gollins S, West N, Sebag-Montefiore D, Susnerwala S, Falk S, Brown N, Saunders M, Quirke P, Ray R, Parsons P, Griffiths G, Maughan T, Adams R, Hurt C. A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS. British Journal of Cancer. PMID 30116024 DOI: 10.1038/s41416-018-0209-4 |
0.197 |
|
| 2024 |
Pennel KAF, Hatthakarnkul P, Wood CS, Lian GY, Al-Badran SSF, Quinn JA, Legrini A, Inthagard J, Alexander PG, van Wyk H, Kurniawan A, Hashmi U, Gillespie MA, Mills M, Ammar A, ... ... Saunders M, et al. JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors. Journal of Experimental & Clinical Cancer Research : Cr. 43: 64. PMID 38424636 DOI: 10.1186/s13046-024-02958-4 |
0.195 |
|
| 2021 |
Iveson TJ, Sobrero AF, Yoshino T, Souglakos I, Ou FS, Meyers JP, Shi Q, Grothey A, Saunders MP, Labianca R, Yamanaka T, Boukovinas I, Hollander NH, Galli F, Yamazaki K, et al. Duration of Adjuvant Doublet Chemotherapy (3 or 6 months) in Patients With High-Risk Stage II Colorectal Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2001330. PMID 33439695 DOI: 10.1200/JCO.20.01330 |
0.195 |
|
| 2017 |
Lenz HJ, Philip P, Saunders M, Kolevska T, Mukherjee K, Samuel L, Bondarde S, Dobbs T, Tagliaferri M, Hoch U, Hannah AL, Berkowitz M. Randomized study of etirinotecan pegol versus irinotecan as second-line treatment for metastatic colorectal cancer. Cancer Chemotherapy and Pharmacology. PMID 29043412 DOI: 10.1007/s00280-017-3438-y |
0.193 |
|
| 2020 |
Sekhar H, Malcomson L, Kochhar R, Sperrin M, Alam N, Chakrbarty B, Fulford PE, Wilson MS, O'Dwyer ST, Saunders MP, Renehan AG. Temporal improvements in loco-regional failure and survival in patients with anal cancer treated with chemo-radiotherapy: treatment cohort study (1990-2014). British Journal of Cancer. PMID 31932755 DOI: 10.1038/s41416-019-0689-x |
0.192 |
|
| 2011 |
Gollins S, Sun Myint A, Haylock B, Wise M, Saunders M, Neupane R, Essapen S, Samuel L, Dougal M, Lloyd A, Morris J, Topham C, Susnerwala S. Preoperative chemoradiotherapy using concurrent capecitabine and irinotecan in magnetic resonance imaging-defined locally advanced rectal cancer: impact on long-term clinical outcomes. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1042-9. PMID 21263095 DOI: 10.1200/JCO.2010.29.7697 |
0.19 |
|
| 2024 |
Frei AL, McGuigan A, Sinha RRAK, Jabbar F, Gneo L, Tomasevic T, Harkin A, Iveson T, Saunders MP, Oien KA, Maka N, Pezzella F, Campo L, Browne M, Glaire M, et al. Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis. The Lancet. Oncology. 25: 198-211. PMID 38301689 DOI: 10.1016/S1470-2045(23)00560-0 |
0.184 |
|
| 2022 |
Mbanu P, Saunders MP, Mistry H, Mercer J, Malcomson L, Yousif S, Price G, Kochhar R, Renehan AG, van Herk M, Osorio EV. Clinical and radiomics prediction of complete response in rectal cancer pre-chemoradiotherapy. Physics and Imaging in Radiation Oncology. 23: 48-53. PMID 35800297 DOI: 10.1016/j.phro.2022.06.010 |
0.181 |
|
| 2019 |
Iveson T, Boyd KA, Kerr RS, Robles-Zurita J, Saunders MP, Briggs AH, Cassidy J, Hollander NH, Tabernero J, Haydon A, Glimelius B, Harkin A, Allan K, McQueen J, Pearson S, et al. 3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT. Health Technology Assessment (Winchester, England). 23: 1-88. PMID 31852579 DOI: 10.3310/Hta23640 |
0.179 |
|
| 2012 |
Njeh CF, Saunders MW, Langton CM. Accelerated partial breast irradiation using external beam conformal radiation therapy: a review. Critical Reviews in Oncology/Hematology. 81: 1-20. PMID 21376625 DOI: 10.1016/j.critrevonc.2011.01.011 |
0.179 |
|
| 2010 |
Alam N, Sheikh H, Saunders M. Colorectal cancer: a decade of progress. British Journal of Hospital Medicine (London, England : 2005). 71: 682-5. PMID 21135764 DOI: 10.12968/hmed.2010.71.12.682 |
0.179 |
|
| 2018 |
Jayson GC, Zhou C, Backen A, Horsley L, Marti-Marti K, Shaw D, Mescallado N, Clamp A, Saunders MP, Valle JW, Mullamitha S, Braun M, Hasan J, McEntee D, Simpson K, et al. Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancer. Nature Communications. 9: 4672. PMID 30405103 DOI: 10.1038/s41467-018-07174-1 |
0.179 |
|
| 2019 |
Ogungbenro K, Patel A, Saunders M, Clark J, Duncombe R. An evaluation of cetuximab dosing strategies using pharmacokinetics and cost analysis. The Journal of Pharmacy and Pharmacology. PMID 31124587 DOI: 10.1111/jphp.13108 |
0.177 |
|
| 2009 |
Molassiotis A, Brearley S, Saunders M, Craven O, Wardley A, Farrell C, Swindell R, Todd C, Luker K. Effectiveness of a home care nursing program in the symptom management of patients with colorectal and breast cancer receiving oral chemotherapy: a randomized, controlled trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 6191-8. PMID 19917849 DOI: 10.1200/Jco.2008.20.6755 |
0.176 |
|
| 2020 |
Alexander PG, Roseweir AK, Pennel KAF, van Wyk HC, Powell AGMT, McMillan DC, Horgan PG, Kelly C, Hay J, Sansom O, Harkin A, Roxburgh CSD, Graham J, Church DN, Tomlinson I, ... Saunders M, et al. The Glasgow Microenvironment Score associates with prognosis and adjuvant chemotherapy response in colorectal cancer. British Journal of Cancer. PMID 33223535 DOI: 10.1038/s41416-020-01168-x |
0.171 |
|
| 2020 |
Sekhar H, Kochhar R, Carrington B, Kaye T, Tolan D, Saunders MP, Sperrin M, Sebag-Montefiore D, van Herk M, Renehan AG. Three-dimensional (3D) magnetic resonance volume assessment and loco-regional failure in anal cancer: early evaluation case-control study. Bmc Cancer. 20: 1165. PMID 33256671 DOI: 10.1186/s12885-020-07613-7 |
0.17 |
|
| 2022 |
Bhullar D, O'Dwyer S, Wilson M, Saunders MP, Kochhar R, Barriuso J, Aziz O. RAS Mutation Status Should Not Be Used to Predict Outcome from Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases. Annals of Surgical Oncology. PMID 36400886 DOI: 10.1245/s10434-022-12704-9 |
0.165 |
|
| 2020 |
Roseweir AK, Park JH, Hoorn ST, Powell AG, Aherne S, Roxburgh CS, McMillan DC, Horgan PG, Ryan E, Sheahan K, Vermeulen L, Paul J, Harkin A, Graham J, Sansom O, ... ... Saunders M, et al. Histological phenotypic subtypes predict recurrence risk and response to adjuvant chemotherapy in patients with stage III colorectal cancer. The Journal of Pathology. Clinical Research. PMID 32401426 DOI: 10.1002/cjp2.171 |
0.164 |
|
| 2010 |
Njeh CF, Saunders MW, Langton CM. Accelerated Partial Breast Irradiation (APBI): A review of available techniques. Radiation Oncology (London, England). 5: 90. PMID 20920346 DOI: 10.1186/1748-717X-5-90 |
0.161 |
|
| 2020 |
Barriuso J, Nagaraju RT, Belgamwar S, Chakrabarty B, Burghel GJ, Schlecht H, Foster L, Kilgour E, Wallace AJ, Braun M, Dive C, Evans DG, Bristow RG, Saunders MP, O'Dwyer ST, et al. Early adaptation of colorectal cancer cells to the peritoneal cavity is associated with activation of 'stemness' programs and local inflammation. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33257424 DOI: 10.1158/1078-0432.CCR-20-3320 |
0.16 |
|
| 2012 |
Kochhar R, Plumb AA, Carrington BM, Saunders M. Imaging of anal carcinoma. Ajr. American Journal of Roentgenology. 199: W335-44. PMID 22915424 DOI: 10.2214/AJR.11.8027 |
0.159 |
|
| 2018 |
Aziz O, Jaradat I, Chakrabarty B, Selvasekar CR, Fulford PE, Saunders MP, Renehan AG, Wilson MS, O'Dwyer ST. Predicting Survival After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Appendix Adenocarcinoma. Diseases of the Colon and Rectum. PMID 29771808 DOI: 10.1097/DCR.0000000000001076 |
0.158 |
|
| 2020 |
Kamposioras K, Saunders M, Jonathan Lim KH, Marti K, Anderson D, Cutting M, McCool D, Connell J, Simpson L, Hasan J, Braun M, Lavin V, Mullamitha S, Barriuso J. The Impact of Changes in Service Delivery in Patients With Colorectal Cancer During the Initial Phase of the COVID-19 Pandemic. Clinical Colorectal Cancer. PMID 33384244 DOI: 10.1016/j.clcc.2020.11.006 |
0.156 |
|
| 2023 |
Frei AL, McGuigan A, Sinha RR, Glaire MA, Jabbar F, Gneo L, Tomasevic T, Harkin A, Iveson TJ, Saunders M, Oein K, Maka N, Pezella F, Campo L, Hay J, et al. Accounting for intensity variation in image analysis of large-scale multiplexed clinical trial datasets. The Journal of Pathology. Clinical Research. PMID 37697694 DOI: 10.1002/cjp2.342 |
0.154 |
|
| 2018 |
Fish R, Sanders C, Adams R, Brewer J, Brookes ST, DeNardo J, Kochhar R, Saunders MP, Sebag-Montefiore D, Williamson PR, Renehan AG. A core outcome set for clinical trials of chemoradiotherapy interventions for anal cancer (CORMAC): a patient and health-care professional consensus. The Lancet. Gastroenterology & Hepatology. 3: 865-873. PMID 30507470 DOI: 10.1016/S2468-1253(18)30264-4 |
0.153 |
|
| 2007 |
Jansen EPM, Saunders MP, Boot H, Oppedijk V, Dubbelman R, Porritt B, Cats A, Stroom J, Olmos RV, Bartelink H, Verheij M. Prospective study on late renal toxicity following postoperative chemoradiotherapy in gastric cancer. International Journal of Radiation Oncology Biology Physics. 67: 781-785. PMID 17157445 DOI: 10.1016/J.Ijrobp.2006.09.012 |
0.152 |
|
| 2007 |
Mullamitha SA, Ton NC, Parker GJ, Jackson A, Julyan PJ, Roberts C, Buonaccorsi GA, Watson Y, Davies K, Cheung S, Hope L, Valle JW, Radford JA, Lawrance J, Saunders MP, et al. Phase I evaluation of a fully human anti-alphav integrin monoclonal antibody (CNTO 95) in patients with advanced solid tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 2128-35. PMID 17404096 DOI: 10.1158/1078-0432.CCR-06-2779 |
0.151 |
|
| 2023 |
Challoner BR, Woolston A, Lau D, Buzzetti M, Fong C, Barber LJ, Anandappa G, Crux R, Assiotis I, Fenwick K, Begum R, Begum D, Lund T, Sivamanoharan N, Sansano HB, ... ... Saunders M, et al. Genetic and immune landscape evolution in MMR-deficient colorectal cancer. The Journal of Pathology. PMID 37964706 DOI: 10.1002/path.6228 |
0.148 |
|
| 2019 |
Law PJ, Timofeeva M, Fernandez-Rozadilla C, Broderick P, Studd J, Fernandez-Tajes J, Farrington S, Svinti V, Palles C, Orlando G, Sud A, Holroyd A, Penegar S, Theodoratou E, Vaughan-Shaw P, ... ... Saunders M, et al. Association analyses identify 31 new risk loci for colorectal cancer susceptibility. Nature Communications. 10: 2154. PMID 31089142 DOI: 10.1038/S41467-019-09775-W |
0.147 |
|
| 2024 |
Domingo E, Kelly C, Hay J, Sansom O, Maka N, Oien K, Iveson T, Saunders M, Kerr R, Tomlinson I, Edwards J, Harkin A, Nowak M, Koelzer V, Easton A, et al. Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG Studies. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2301648. PMID 38484206 DOI: 10.1200/JCO.23.01648 |
0.144 |
|
| 2013 |
Kelly C, Bhuva N, Harrison M, Buckley A, Saunders M. Use of raltitrexed as an alternative to 5-fluorouracil and capecitabine in cancer patients with cardiac history. European Journal of Cancer (Oxford, England : 1990). 49: 2303-10. PMID 23583220 DOI: 10.1016/j.ejca.2013.03.004 |
0.143 |
|
| 2023 |
Dillon MT, Guevara J, Mohammed K, Patin EC, Smith SA, Dean E, Jones GN, Willis SE, Petrone M, Silva C, Thway K, Bunce C, Roxanis I, Nenclares P, Wilkins A, ... ... Saunders MP, et al. Durable responses to ATR inhibition with ceralasertib in tumors with genomic defects and high inflammation. The Journal of Clinical Investigation. PMID 37934611 DOI: 10.1172/JCI175369 |
0.138 |
|
| 2003 |
Salloum RM, Saunders MP, Mauceri HJ, Hanna NN, Gorski DH, Posner MC, Stratford IJ, Weichselbaum RR. Dual induction of the Epo-Egr-TNF-alpha- plasmid in hypoxic human colon adenocarcinoma produces tumor growth delay. The American Surgeon. 69: 24-7. PMID 12575775 |
0.132 |
|
| 2017 |
Gollins S, West N, Sebag-Montefiore D, Myint AS, Saunders M, Susnerwala S, Quirke P, Essapen S, Samuel L, Sizer B, Worlding J, Southward K, Hemmings G, Tinkler-Hundal E, Taylor M, et al. Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations. British Journal of Cancer. PMID 28859058 DOI: 10.1038/bjc.2017.294 |
0.124 |
|
| 2021 |
Fontana E, Meyers J, Sobrero A, Iveson T, Shields AF, Taieb J, Yoshino T, Souglakos I, Smyth EC, Lordick F, Moehler M, Giraut A, Harkin A, Labianca R, Meyerhardt J, ... ... Saunders M, et al. Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and Oxaliplatin. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2102008. PMID 34752136 DOI: 10.1200/JCO.21.02008 |
0.124 |
|
| 2013 |
Doherty C, Saunders MN. Elective surgical patients' narratives of hospitalization: the co-construction of safety. Social Science & Medicine (1982). 98: 29-36. PMID 24331879 DOI: 10.1016/j.socscimed.2013.08.014 |
0.124 |
|
| 2019 |
Kurzrock R, Hickish T, Wyrwicz L, Saunders M, Wu Q, Stecher M, Mohanty P, Dinarello CA, Simard J. Interleukin-1 receptor antagonist levels predict favorable outcome after bermekimab, a first-in-class true human interleukin-1α antibody, in a phase III randomized study of advanced colorectal cancer. Oncoimmunology. 8: 1551651. PMID 30723583 DOI: 10.1080/2162402X.2018.1551651 |
0.121 |
|
| 2023 |
Saunders MP, Iype R, Kelly C, Crosby J, Kerr R, Harkin A, Allan K, McQueen J, Pearson SR, Cassidy J, Medley LC, Raouf S, Harrison M, Brewster A, Rees C, et al. SCOT: Tumor Sidedness and the Influence of Adjuvant Chemotherapy Duration on Disease Free Survival (DFS). Clinical Colorectal Cancer. PMID 36967267 DOI: 10.1016/j.clcc.2023.02.005 |
0.12 |
|
| 2010 |
Huehn S, La Ragione RM, Anjum M, Saunders M, Woodward MJ, Bunge C, Helmuth R, Hauser E, Guerra B, Beutlich J, Brisabois A, Peters T, Svensson L, Madajczak G, Litrup E, et al. Virulotyping and antimicrobial resistance typing of Salmonella enterica serovars relevant to human health in Europe. Foodborne Pathogens and Disease. 7: 523-35. PMID 20039795 DOI: 10.1089/fpd.2009.0447 |
0.119 |
|
| 2019 |
Pathak R, Tian J, Thacker NA, Morris DM, Ragheb H, Saunders C, Saunders M, Jackson A. Considering tumour volume for motion corrected DWI of colorectal liver metastases increases sensitivity of ADC to detect treatment-induced changes. Scientific Reports. 9: 3828. PMID 30846790 DOI: 10.1038/s41598-019-40565-y |
0.118 |
|
| 2017 |
Sekhar H, Zwahlen M, Trelle S, Malcomson L, Kochhar R, Saunders MP, Sperrin M, van Herk M, Sebag-Montefiore D, Egger M, Renehan AG. Nodal stage migration and prognosis in anal cancer: a systematic review, meta-regression, and simulation study. The Lancet. Oncology. PMID 28802802 DOI: 10.1016/S1470-2045(17)30456-4 |
0.114 |
|
| 2019 |
Gray V, Briggs S, Palles C, Jaeger E, Iveson T, Kerr R, Saunders MP, Paul J, Harkin A, McQueen J, Summers MG, Johnstone E, Wang H, Gatcombe L, Maughan TS, et al. Pattern Recognition Receptor Polymorphisms as Predictors of Oxaliplatin Benefit in Colorectal Cancer. Journal of the National Cancer Institute. PMID 30649440 DOI: 10.1093/Jnci/Djy215 |
0.114 |
|
| 2013 |
Craven O, Hughes CA, Burton A, Saunders MP, Molassiotis A. Is a nurse-led telephone intervention a viable alternative to nurse-led home care and standard care for patients receiving oral capecitabine? Results from a large prospective audit in patients with colorectal cancer. European Journal of Cancer Care. 22: 413-9. PMID 23527965 DOI: 10.1111/ecc.12047 |
0.114 |
|
| 2018 |
Graham PM, Richardson AS, Schapiro BL, Saunders MD, Stewart DM. Spontaneous regression of primary cutaneous diffuse large B-cell lymphoma, leg type with significant T-cell immune response. Jaad Case Reports. 4: 305-309. PMID 29693055 DOI: 10.1016/j.jdcr.2017.10.012 |
0.107 |
|
| 2023 |
Lim KHJ, Ntellas P, Anderson D, Simpson L, Braun M, Adamou M, Barriuso J, Dadouli K, Connell J, Williams J, Germetaki T, Lehwald D, Fitzpatrick N, Cutting M, McCool D, ... ... Saunders M, et al. The Mental Health Burden of Patients with Colorectal Cancer Receiving Care during the COVID-19 Pandemic: Results of the PICO-SM Study. Cancers. 15. PMID 36831568 DOI: 10.3390/cancers15041226 |
0.106 |
|
| 2009 |
AbuOun M, Suthers PF, Jones GI, Carter BR, Saunders MP, Maranas CD, Woodward MJ, Anjum MF. Genome scale reconstruction of a Salmonella metabolic model: comparison of similarity and differences with a commensal Escherichia coli strain. The Journal of Biological Chemistry. 284: 29480-8. PMID 19690172 DOI: 10.1074/jbc.M109.005868 |
0.105 |
|
| 2011 |
Buanz AB, Saunders MH, Basit AW, Gaisford S. Preparation of personalized-dose salbutamol sulphate oral films with thermal ink-jet printing. Pharmaceutical Research. 28: 2386-92. PMID 21544688 DOI: 10.1007/s11095-011-0450-5 |
0.096 |
|
| 2020 |
Gurusamy K, Vale CL, Pizzo E, Bhanot R, Davidson BR, Mould T, Mughal M, Saunders M, Aziz O, O'Dwyer S. Cytoreductive surgery (CRS) with hyperthermic intraoperative peritoneal chemotherapy (HIPEC) versus standard of care (SoC) in people with peritoneal metastases from colorectal, ovarian or gastric origin: protocol for a systematic review and individual participant data (IPD) meta-analyses of effectiveness and cost-effectiveness. Bmj Open. 10: e039314. PMID 32404398 DOI: 10.1136/bmjopen-2020-039314 |
0.093 |
|
| 2020 |
Germetaki T, Nicholls C, Adams RA, Braun M, Rogan J, Moghadam S, Lenfert E, Lukas A, Edelstein DL, Jones FS, Saunders MP. Blood-based mutation testing: concordance with tissue-based testing and mutational changes on progression. Future Oncology (London, England). PMID 32716216 DOI: 10.2217/fon-2020-0523 |
0.091 |
|
| 2006 |
Saunders M, Guinane C, MacFarlane M, Tarr K, Bhatti MT, Pincus DW. A diplopia dilemma. Survey of Ophthalmology. 51: 68-74. PMID 16414363 DOI: 10.1016/j.survophthal.2005.11.004 |
0.089 |
|
| 2015 |
Doherty C, Stavropoulou C, Saunders MN, Brown T. The consent process: Enabling or disabling patients' active participation? Health (London, England : 1997). PMID 26487687 DOI: 10.1177/1363459315611870 |
0.084 |
|
| 2015 |
Tickle S, Howells L, O'Dowd V, Starkie D, Whale K, Saunders M, Lee D, Lightwood D. A fully automated primary screening system for the discovery of therapeutic antibodies directly from B cells. Journal of Biomolecular Screening. 20: 492-7. PMID 25548140 DOI: 10.1177/1087057114564760 |
0.083 |
|
| 2006 |
Manning P, Newington JE, Robson HR, Saunders M, Eggers T, Bradford MA, Bardgett RD, Bonkowski M, Ellis RJ, Gange AC, Grayston SJ, Kandeler E, Marhan S, Reid E, Tscherko D, et al. Decoupling the direct and indirect effects of nitrogen deposition on ecosystem function. Ecology Letters. 9: 1015-24. PMID 16925650 DOI: 10.1111/J.1461-0248.2006.00959.X |
0.077 |
|
| 2009 |
Gaisford S, Verma A, Saunders M, Royall PG. Monitoring crystallisation of drugs from fast-dissolving oral films with isothermal calorimetry. International Journal of Pharmaceutics. 380: 105-11. PMID 19596058 DOI: 10.1016/J.Ijpharm.2009.07.006 |
0.076 |
|
| 2006 |
Buckton G, Adeniyi AA, Saunders M, Ambarkhane A. HyperDSC studies of amorphous polyvinylpyrrolidone in a model wet granulation system. International Journal of Pharmaceutics. 312: 61-5. PMID 16500057 DOI: 10.1016/j.ijpharm.2005.12.048 |
0.073 |
|
| 2017 |
Harrod ME, Couzos S, Ward J, Saunders M, Donovan B, Hammond B, Delaney-Thiele D, Belfrage M, Williams S, Smith LW, Kaldor JM. Gonorrhoea testing and positivity in non-remote Aboriginal Community Controlled Health Services. Sexual Health. PMID 28641073 DOI: 10.1071/SH16046 |
0.072 |
|
| 2022 |
Bhullar D, O'Dwyer S, Wilson M, Saunders MP, Kochhar R, Barriuso J, Aziz O. ASO Visual Abstract: RAS Mutation Status Should not be Used to Predict Outcome from Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases. Annals of Surgical Oncology. PMID 36404378 DOI: 10.1245/s10434-022-12780-x |
0.072 |
|
| 2019 |
Rettberg P, Antunes A, Brucato J, Cabezas P, Collins G, Haddaji A, Kminek G, Leuko S, McKenna-Lawlor S, Moissl-Eichinger C, Fellous JL, Olsson-Francis K, Pearce D, Rabbow E, Royle S, ... Saunders M, et al. Biological Contamination Prevention for Outer Solar System Moons of Astrobiological Interest: What Do We Need to Know? Astrobiology. PMID 30762429 DOI: 10.1089/Ast.2018.1996 |
0.068 |
|
| 2004 |
Saunders M, Podluii K, Shergill S, Buckton G, Royall P. The potential of high speed DSC (hyper-DSC) for the detection and quantification of small amounts of amorphous content in predominantly crystalline samples. International Journal of Pharmaceutics. 274: 35-40. PMID 15072780 DOI: 10.1016/J.Ijpharm.2004.01.018 |
0.06 |
|
| 2016 |
Rettberg P, Anesio AM, Baker VR, Baross JA, Cady SL, Detsis E, Foreman CM, Hauber E, Ori GG, Pearce DA, Renno NO, Ruvkun G, Sattler B, Saunders MP, Smith DH, et al. Planetary Protection and Mars Special Regions-A Suggestion for Updating the Definition. Astrobiology. PMID 26848950 DOI: 10.1089/Ast.2016.1472 |
0.048 |
|
| 2009 |
Njeh CF, Raines TW, Saunders MW. Determination of the photon beam attenuation by the Brainlab imaging couch: angular and field size dependence. Journal of Applied Clinical Medical Physics. 10: 16-27. PMID 19692980 DOI: 10.1120/jacmp.v10i3.2979 |
0.047 |
|
| 2008 |
Saunders MA, Lea AS. Large contribution of sea surface warming to recent increase in Atlantic hurricane activity. Nature. 451: 557-60. PMID 18235498 DOI: 10.1038/nature06422 |
0.046 |
|
| 2009 |
Hancock G, Morrison M, Saunders M. Vibrational relaxation of NO (v = 1-16) with NO, N2O, NO2, He and Ar studied by time-resolved Fourier transform infrared emission. Physical Chemistry Chemical Physics : Pccp. 11: 8507-15. PMID 19774281 DOI: 10.1039/B909195E |
0.045 |
|
| 2014 |
Harrod ME, Couzos S, Delaney-Thiele D, Dore GJ, Hammond B, Saunders M, Belfrage M, Williams S, Kaldor JM, Ward J. Markers of hepatitis B infection and immunity in patients attending Aboriginal community controlled health services. The Medical Journal of Australia. 201: 339-42. PMID 25222458 DOI: 10.5694/mja14.00121 |
0.042 |
|
| 2014 |
Ward J, Costello-Czok M, Willis J, Saunders M, Shannon C. So far, so good: Maintenance of prevention is required to stem HIV incidence in Aboriginal and Torres Strait Islander communities in Australia. Aids Education and Prevention : Official Publication of the International Society For Aids Education. 26: 267-79. PMID 24846489 DOI: 10.1521/aeap.2014.26.3.267 |
0.04 |
|
| 2007 |
Saunders M, Taylor KM, Craig DQ, Palin K, Robson H. High sensitivity differential scanning calorimetry study of DNA-cationic liposome complexes. Pharmaceutical Research. 24: 1954-61. PMID 17551810 DOI: 10.1007/S11095-007-9325-1 |
0.033 |
|
| 2020 |
Floyd CG, Landa S, Saunders MA, Volk F. The Moderating Influence of Moral Disapproval of Pornography on Couples' Sexual and Relationship Satisfaction. Journal of Sex & Marital Therapy. 1-23. PMID 32573369 DOI: 10.1080/0092623X.2020.1783409 |
0.033 |
|
| 2015 |
Gokul A, Krishnan T, Emanuel PO, Saunders M, McGhee CN. Persisting extreme acute corneal hydrops with a giant intrastromal cleft secondary to keratoconus. Clinical & Experimental Optometry : Journal of the Australian Optometrical Association. PMID 25754363 DOI: 10.1111/cxo.12260 |
0.031 |
|
| 2016 |
Stavropoulou C, Saunders MN, Doherty C. Consent to treatment in the UK: time for practice to reflect the law. Journal of Health Services Research & Policy. PMID 26841963 DOI: 10.1177/1355819616629502 |
0.03 |
|
| 2020 |
Owens JM, Saunders M. Louis Corwin, Jr. (1926-2019). Veterinary Radiology & Ultrasound : the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association. PMID 33216390 DOI: 10.1111/vru.12923 |
0.027 |
|
| 2019 |
Wells JC, Saunders MA, Lea AS, Cortina-Borja M, Shirley MK. Beyond Bergmann's rule: Global variability in human body composition is associated with annual average precipitation and annual temperature volatility. American Journal of Physical Anthropology. PMID 31318051 DOI: 10.1002/ajpa.23890 |
0.025 |
|
| 2005 |
Saunders MA, Lea AS. Seasonal prediction of hurricane activity reaching the coast of the United States. Nature. 434: 1005-8. PMID 15846342 DOI: 10.1038/nature03454 |
0.022 |
|
| 2021 |
Saunders M. Kevin Kealy, M.V.M., M.R.C.V.S., D.V.R. (1921-2021). Veterinary Radiology & Ultrasound : the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association. PMID 34585479 DOI: 10.1111/vru.13013 |
0.021 |
|
| 2014 |
Ward J, Goller J, Ali H, Bowring A, Couzos S, Saunders M, Yau P, Kaldor JM, Hellard M, Guy RJ, Donovan B. Chlamydia among Australian Aboriginal and/or Torres Strait Islander people attending sexual health services, general practices and Aboriginal community controlled health services. Bmc Health Services Research. 14: 285. PMID 24981418 DOI: 10.1186/1472-6963-14-285 |
0.021 |
|
| 2012 |
Goller JL, Ward J, Saunders M, Couzos S, Kaldor J, Hellard MA. Chlamydia sentinel surveillance in Aboriginal Community Controlled Health Services finds higher testing and positivity rates among younger people. Australian and New Zealand Journal of Public Health. 36: 577-81. PMID 23216501 DOI: 10.1111/j.1753-6405.2012.00929.x |
0.012 |
|
| 2006 |
Carvalho A, Hancock G, Saunders M. The reaction products of the 193 nm photolysis of vinyl bromide and vinyl chloride studied by time-resolved Fourier transform infrared emission spectroscopy. Physical Chemistry Chemical Physics : Pccp. 8: 4337-46. PMID 16986077 DOI: 10.1039/B607882F |
0.011 |
|
| 2022 |
Saunders M. Arthur Robert "Bob" Twardock (1931-2021). Veterinary Radiology & Ultrasound : the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association. PMID 35679482 DOI: 10.1111/vru.13124 |
0.01 |
|
| 2008 |
Hancock G, Saunders M. Vibrational distribution in NO(X2Pi) formed by self quenching of NO A 2Sigma+ (v=0). Physical Chemistry Chemical Physics : Pccp. 10: 2014-9. PMID 18688353 DOI: 10.1039/B719065D |
0.01 |
|
| Hide low-probability matches. |